Provided by Tiger Trade Technology Pte. Ltd.

NeoGenomics

7.96
-0.2200-2.69%
Post-market: 8.110.1500+1.88%18:03 EDT
Volume:3.31M
Turnover:26.45M
Market Cap:1.03B
PE:-9.44
High:8.24
Open:8.15
Low:7.86
Close:8.18
52wk High:13.74
52wk Low:4.72
Shares:129.39M
Float Shares:119.99M
Volume Ratio:2.39
T/O Rate:2.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8433
EPS(LYR):-0.8433
ROE:-12.42%
ROA:-2.90%
PB:1.23
PE(LYR):-9.44

Loading ...

Press Release: NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026

Dow Jones
·
Jan 27

Guardant Health, Jabil, NeoGenomics, Darden, Cormedix Insider Moves

TIPRANKS
·
Jan 24

Don't Ignore The Insider Selling In NeoGenomics

Simply Wall St.
·
Jan 23

NEO Battery Materials Seeks Up to C$7 Million in Private Placement to Expand Battery Manufacturing

TIPRANKS
·
Jan 20

NVISAGE Technologies to Present NEO-E Portable Launch Monitor at Golfmesse 2026

prnewswire
·
Jan 19

NeoGenomics: Solid Execution and Clean Quarter Support Fair Valuation, Justifying Hold Amid CFO Transition and Limited Medium-Term Visibility

TIPRANKS
·
Jan 13

NeoGenomics Price Target Maintained With a $14.00/Share by Needham

Dow Jones
·
Jan 12

NeoGenomics Appoints Abhishek Jain to CFO Role

Dow Jones
·
Jan 12

NeoGenomics reports preliminary Q4 revenue $190M, consensus $188.07M

TIPRANKS
·
Jan 12

NeoGenomics CFO Jeff Sherman to retire, Abhishek Jain to succeed

TIPRANKS
·
Jan 12

NeoGenomics prelim Q4 revenue slightly beats estimates, names insider as CFO

Reuters
·
Jan 12

Neogenomics Q4 Revenue USD 190 Million VS. Ibes Estimate USD 188.8 Million

THOMSON REUTERS
·
Jan 12

Neogenomics Inc FY2025 REV View $725.1 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
Jan 12

Neogenomics Inc - Abhishek Jain to Become CFO on March 2, 2026

THOMSON REUTERS
·
Jan 12

Neogenomics Inc - Expects Q4 2025 Revenue of $190 Mln

THOMSON REUTERS
·
Jan 12

Neogenomics Inc - Current CFO Jeff Sherman Retiring, Transitioning to Evp

THOMSON REUTERS
·
Jan 12

Press Release: NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue

Dow Jones
·
Jan 12

BTIG Sticks to Its Hold Rating for NeoGenomics (NEO)

TIPRANKS
·
Jan 08

NeoGenomics Inc. Files Initial Beneficial Ownership Statement for Director John P. Kenny

Reuters
·
Jan 06

BUZZ-Life sciences and contract research stocks navigate turbulence in 2025

Reuters
·
Dec 31, 2025